Evidence method
Level · gp.fundamentals.capex_revenue_ratio
29.06% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ROIV · Jun 30, 2026
Roivant Sciences Ltd.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001635088-26-000090General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-18758.95% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-33.55% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-25380.93% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14009.43% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5779.61% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20236/8 normalizedLevel 3Sep 30, 20236/8 normalizedLevel 3Dec 31, 20236/8 normalizedLevel 3Mar 31, 20246/8 normalizedLevel 3Jun 30, 20247/8 normalizedLevel 3Sep 30, 20246/6 normalizedLevel 3Dec 31, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 99.38%
- Current
- 29.06%
- Delta
- -70.33%
- Previous
- -9084.13%
- Current
- -18758.95%
- Delta
- -9674.82%
- Previous
- -71.57%
- Current
- -33.55%
- Delta
- 38.02%
- Previous
- -6235.69%
- Current
- -25380.93%
- Delta
- -19145.24%
- Previous
- 8254.38%
- Current
- 14009.43%
- Delta
- 5755.05%
- Previous
- 4190.86%
- Current
- 5779.61%
- Delta
- 1588.75%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 85%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 83%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 78%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 74%
- Compared
- 6 dimensions
- Coverage
- 100%
- Similarity
- 21%
- Compared
- 5 dimensions
- Coverage
- 83%
Research Graph
Related governed research
Analogous To · ROIV state analogue 5 →Analogous To · ROIV state analogue 4 →Analogous To · ROIV state analogue 3 →Analogous To · ROIV state analogue 2 →Compared To · Pharmaceutical Preparations peers →Analogous To · ROIV state analogue 1 →Derived From · ROIV Company Quality Vector →Has State · Roivant Sciences Ltd. →Transitioned To · ROIV Fundamental State →Transitioned To · ROIV CAPEX_INTENSITY_DECREASED →Transitioned To · ROIV CASH_GENERATION_DECREASED →Transitioned To · ROIV GROWTH_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.